AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

The Global Synthetic Biology Market is estimated to be valued at USD 13.83 billion in 2023 and is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 17.30% over the forecast period ...

XOD Aesthetics on Demand (XOD, Inc.), the pioneering provider of advanced mobile aesthetic solutions, is excited to announce Dr. Bertha Baum, a renowned dermatologist and cosmetic surgeon, as its ...

Next-generation sequencing (NGS) is a powerful tool to help you and your ... Liquid biopsy examines circulating tumor DNA (ctDNA) that’s shed from dead tumor cells in your bloodstream. The test ...

Anivive, a software-driven pet health company, announces the expansion of its Long Beach lab to accommodate increased demand for its specialty pathology services through Vidium, a leader in veterinary ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

China has banned the import of Illumina’s next-generation sequencing ... and use a technology known as sequencing by synthesis (SBS) to enhance DNA short-read sequence generation.

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN stock.

Market OverviewGlobal Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of ...